Oral beclomethasone dipropionate in pediatric active ulcerative colitis: a comparison trial with mesalazine.

@article{Romano2010OralBD,
  title={Oral beclomethasone dipropionate in pediatric active ulcerative colitis: a comparison trial with mesalazine.},
  author={Claudio Romano and Annalisa Famiani and Donatella Comito and Paolo Rossi and Vanessa Raffa and Walter Fries},
  journal={Journal of pediatric gastroenterology and nutrition},
  year={2010},
  volume={50 4},
  pages={
          385-9
        }
}
OBJECTIVE The objective of the study was to evaluate the clinical efficacy of oral beclomethasone diproprionate (BDP) in inducing clinical and endoscopic remission in children with mild to moderate active ulcerative colitis (UC). PATIENTS AND METHODS Thirty patients with active UC (pancolitis or left-sided colitis) were enrolled in an open-labeled, randomized, head-to-head study. Group 1 (n = 15) received oral BDP (5 mg/day) for 8 weeks, followed by maintenance therapy with oral mesalazine, 5… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter?

  • Journal of gastrointestinal and liver diseases : JGLD
  • 2013
VIEW 13 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED

Similar Papers

Loading similar papers…